Psychometric properties of the Weight Locus of Control Scale (MWLCS): study with Spanish individuals of different anthropometric nutritional status.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 08 04 2019
accepted: 26 09 2019
pubmed: 13 10 2019
medline: 24 6 2021
entrez: 13 10 2019
Statut: ppublish

Résumé

The Multidimensional Weight Locus of Control Scale (MWLCS) measures a person's beliefs regarding the locus of control or lack of locus of control over his/her body weight. We aim to evaluate the factorial structure and psychometric properties of the MWLCS with Spanish normal weight, overweight and obese samples. The research was carried out in two different studies. The first included a sample of 140 normal weight participants, selected out of a 274 sample recruited with an online survey. Study 2 was carried out in a sample of 633 participants recruited from the PREDIMED-Plus study. Out of them, 558 participants fulfilled the weight criteria and were categorized into: overweight (BMI 25 - < 29.99; N = 170), obese class I (BMI 30 - < 34.99; N = 266), and obese class II (BMI 35 - < 39.99; N = 122). Exploratory (EFA) and confirmatory (CFA) factor analyses were used to evaluate the factor structure of the MWLCS, and reliabilities and Spearman's correlations were estimated. Invariance measurement was tested across the three subgroups of weight in Study 2. A three-factor structure indicating weight locus of control factors (internal, chance, and powerful others) was supported, both via EFA in the normal weight sample and CFA in the overweight and obese samples. In the normal weight sample, the powerful others dimension was positively related to BMI and the dimensions of the Dutch Eating Behaviors Questionnaire. Additionally, the scale showed evidence of scalar invariance across the groups with different weight conditions. This scale seems to be a psychometrically appropriate instrument and its use is highly recommended when designing interventions for overweight or obese individuals. Level V, descriptive study.

Identifiants

pubmed: 31605367
doi: 10.1007/s40519-019-00788-4
pii: 10.1007/s40519-019-00788-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1533-1542

Auteurs

A Cebolla (A)

Department Personality, Evaluation and Psychological Treatment, Universitat de València, Avda. Blasco Ibáñez, 21, 46010, València, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.

C Botella (C)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Basic Psychology, Clinic and Psychobiology, Universitat Jaume I, Castelló, Spain.

L Galiana (L)

Department of Methodology for the Behavioral Sciences, Universitat de València, València, Spain.

F Fernández-Aranda (F)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain.

E Toledo (E)

Department of Preventive Medicine and Public Health, University of Navarra, Institute for Health Research, Pamplona, Spain.

D Corella (D)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Jordi Salas-Salvadó (J)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Biochemistry and Biotechnology, Nutrition unit; Institut d'Investigació Sanitària Pere Virgili (IISPV); University Hospital of Sant Joan de Reus, Nutrition Unit, Universitat Rovira i Virgili, Reus, Spain.

M Fitó (M)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Hospital del Mar Research Institute (IMIM), Barcelona, Spain.

D Romaguera (D)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Instituto de Investigación Sanitaria de Illes Balears (IdISBa), University Hospital of Son Espases, Palma de Mallorca, Spain.

J Wärnberg (J)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Nursing, University of Málaga-IBIMA, Málaga, Spain.

L L Serra-Majem (LL)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), Preventive Medicine Service, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, University of Las Palmas de Gran Canaria, Las Palmas, Spain.

X Pintó (X)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Lipid Unit, Department of Internal Medicine, Bellvitge BiomedicalResearch Institute (IDIBELL)-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

P Buil-Cosiales (P)

Servicio Navarro de Salud-Atención Primaria, Institute for Health Research, Pamplona, Spain.

J V Sorlí (JV)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

A Díaz-López (A)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Biochemistry and Biotechnology, Nutrition unit; Institut d'Investigació Sanitària Pere Virgili (IISPV); University Hospital of Sant Joan de Reus, Nutrition Unit, Universitat Rovira i Virgili, Reus, Spain.

R De la Torre (R)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Hospital del Mar Research Institute (IMIM), Barcelona, Spain.

M Fernández de Mott (MF)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Nursing, University of Málaga-IBIMA, Málaga, Spain.

B V Díaz González (BV)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), Preventive Medicine Service, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, University of Las Palmas de Gran Canaria, Las Palmas, Spain.

E Corbella (E)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Lipid Unit, Department of Internal Medicine, Bellvitge BiomedicalResearch Institute (IDIBELL)-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

A Yañez (A)

CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.
Department of Nursing and Physiotherapy, Universitat de les Illes Balears, Palma de Mallorca, Spain.

R Baños (R)

Department Personality, Evaluation and Psychological Treatment, Universitat de València, Avda. Blasco Ibáñez, 21, 46010, València, Spain. banos@uv.es.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain. banos@uv.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH